National Research (NASDAQ:NRC) Hits New 12-Month Low at $24.19

National Research Co. (NASDAQ:NRC) shares reached a new 52-week low on Tuesday . The company traded as low as $24.19 and last traded at $24.25, with a volume of 6962 shares traded. The stock had previously closed at $24.87.

National Research Trading Down 1.9 %

The firm has a market capitalization of $549.24 million, a P/E ratio of 18.55 and a beta of 0.56. The stock’s 50-day simple moving average is $29.70 and its two-hundred day simple moving average is $35.82. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.41 and a quick ratio of 0.41.

National Research (NASDAQ:NRC) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter. The business had revenue of $35.31 million during the quarter. National Research had a net margin of 20.60% and a return on equity of 54.83%.

National Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Friday, June 28th will be given a $0.12 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.09%. National Research’s payout ratio is currently 38.71%.

Hedge Funds Weigh In On National Research

Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of National Research by 1.1% during the third quarter. Vanguard Group Inc. now owns 980,693 shares of the company’s stock worth $43,513,000 after acquiring an additional 10,454 shares during the last quarter. Conestoga Capital Advisors LLC boosted its position in shares of National Research by 0.5% during the first quarter. Conestoga Capital Advisors LLC now owns 784,656 shares of the company’s stock worth $31,080,000 after acquiring an additional 3,850 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of National Research by 1.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company’s stock worth $25,176,000 after acquiring an additional 7,531 shares during the last quarter. iA Global Asset Management Inc. bought a new position in shares of National Research during the third quarter worth $11,124,000. Finally, Comerica Bank bought a new position in shares of National Research during the third quarter worth $6,939,000. 47.26% of the stock is currently owned by institutional investors.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.